Loading...
•
Jun 30, 2024
Revvity Q2 2024 Earnings Report
Reported mixed results with revenue slightly declining but adjusted EPS meeting expectations, and full-year adjusted EPS guidance was raised.
Key Takeaways
Revvity reported GAAP revenue of $692 million, a decrease from $709 million in the same period last year. GAAP EPS was $0.45, up from $0.28 year-over-year, while adjusted EPS was $1.22, slightly up from $1.21 in the previous year. The company is updating its full year revenue guidance to $2.77-$2.79 billion and raising its adjusted EPS guidance to a range of $4.70-$4.80.
Revenue of $692 million, a (2)% reported growth and (1)% organic growth.
GAAP EPS of $0.45; Adjusted EPS from continuing operations of $1.22.
GAAP operating income from continuing operations for the quarter was $86 million.
Full year 2024 adjusted EPS guidance was raised to $4.70-$4.80.
Revvity
Revvity
Revvity Revenue by Segment
Revenue by Segment
Life Sciences Revenue
CapyFin.comDiagnostics Revenue
CapyFin.com Forward Guidance
The Company is updating its full year revenue guidance to $2.77-$2.79 billion to reflect recent changes in foreign currency exchange rates and assumes 2% organic revenue growth. The Company is also raising its adjusted EPS guidance to a range of $4.70-$4.80.
Revenue & Expenses
Visualization of income flow from segment revenue to net income